In summary, our study demonstrates that GEF sensitizes human RCC cells to TRAIL-induced apoptosis by upregulating DR4/5 and modulating apoptotic protein expression (Figure 7). This evidence concerns the gene TNFRSF10A and renal cell carcinoma.